Serum uric acid level reduction, cardiovascular outcome, and mortality: comment on the article by Ioachimescu et al

Arthritis Rheum. 2008 Aug;58(8):2585-6; author reply 2586. doi: 10.1002/art.23738.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticholesteremic Agents / therapeutic use
  • Aspirin / therapeutic use
  • Atorvastatin
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / mortality
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Predictive Value of Tests
  • Pyrroles / therapeutic use
  • Treatment Outcome
  • Uric Acid / blood*

Substances

  • Anticholesteremic Agents
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Pyrroles
  • Uric Acid
  • Atorvastatin
  • Aspirin